T-cell subset counts and serum immunoglobulin concentrations in patients with chronic renal failure at the Kenyatta National Hospital

East African Medical Journal

Volumn 75, Issue 5, 1998, Pages 271-273

  Gogo, K O ^a   McLigeyo, S O ^b   Bwayo, J J ^c   Mumo, J M ^b  

^a EGERTON UNIVERSITY   (Kenya)

^b UNIVERSITY OF NAIROBI   (Kenya)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADOLESCENT; ADULT; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; FEMALE; FLOW CYTOMETRY; HEMODIALYSIS; HUMAN; IMMUNODIFFUSION; IMMUNOGLOBULIN BLOOD LEVEL; KENYA; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MALE; SCHOOL CHILD; T LYMPHOCYTE SUBPOPULATION;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CD4-CD8 RATIO; CREATININE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; KENYA; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 0031770181     PISSN: 0012835X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Chatenoud, L, Herbelin, A., Beaurain, G. and Descamps-Latscha, B. Immune deficiency of the uraemic patients. Adv. Nephrol. 1990; 19:259-274.
2. Moran J, Blumestein M. and Garland H.J. Immunodeficiencies in chronic renal failure; In: Gurland H. J., Moran J., Wetzels, E (eds); Immunological Perspectives in Chronic Renal Failure. Contrib. Nephrol. Basel, Karger, 1990; 86:91-110.
3. Himmelfarb, J. and Hakim R. M. Biocompatibility and risk of infection in haemodialysis patients. Nephrol. Dial. Transplant. 1994; 9(suppl 2): 138-144.
4. Haag-Weber, M. and Horl W. H. Dysfunction of polymorphonuclear leukocytes in uraemia. Semin. Nephrol. 1996; 16:192-201.
5. Haag-Weber M. and Horl W. H. The immune system in uraemia and during its treatment. New Horizons 1995; 3:669-679.
6. Descamps-Latscha, B. and Chatenoud L. B. T cells and B cells in chronic renal failure. Semin. Nephrol. 1996; 16:183-191.
7. Cohen G, Haag-Weber M. and Horl W.H. Immune dysfunction in uraemia. Kidney Int. 1997; 52(suppl 62):S79-S82.
8. Souzana, S D, Takashi, A, Seiya O, Naoko K, Masatoshi, F., Hideki, H. and Aknori N. Cellular immunity in haemodialysis patients: A quantitative analysis of immune cell subsets by flow cytometry. Amer. J. Nephrol. 1995; 15:57-65.
9. Matsumoto Y. Abnormalities of cellular immunity in uraemic patients. Jpn. J. Nephrol. 1993; 35:733-742.
10. Sunder-plassmann G, Heinz G., Wagner, L, Prychzy B. and Gerfler K. T-cell selection and T-cell receptor variable beta chain usage in chronic haemodialysis patients. Clin. Nephrol. 1992; 37:252-259.
11. Cockcroft, D.W. and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron. 1976; 16: 31-41.
12. Paul-Ehrlich Federal Agency of Sera Vaccines (Germany). Enzyme Immunoassay for detection of IgG antibodies of HIV-1 and HIV-2. 1991; OWGE G50 01417(0563):9-15.
13. Mancini, G., Carbonara, A O. and Heremans J.F. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 1965; 2:235.
14. Goldblum, S.E. and Reed W.P. Host defences and immunologic alterations associated with chronic haemodialysis. Ann. Intern. Med. 1980; 93:597-613.
15. Revillard, J P. Immunological alterations in chronic renal insufficiency. Adv. Nephrol. 1979; 8:365-382.
16. Brender B C, Curtis J L, Nagel J E, Chrest F J, Keaus E S, Briefel G. R. and Adler W.H. Analysis of immune status of haemodialysed adults: Association with prior transfusions. Kidney Int. 1984; 26:436-443.
17. Decamps-Latsacha B. and Herbeline A. Long term dialysis and cellular immunity: A critical survey. Kidney Int. 1993; 43 (suppl 41) :135-142.
18. Raska K., Rascova J., Shea S.M., Frankel R.M., Wood R.H., Liffer J, Ghorbial, I., Esinger, R.P. and Homer J. T-cell subsets and cellular immunity in the end stage renal disease. Amer. J Med. 1983; 75:734-740.
19. Waltzer W.C., Bachvaroff, R.J., Raisbeck, A, Egelandsdal B., Pullis, C, Shen E. and Raparot T.F. Immunological monitoring in patients with end stage renal disease. J. Clin. Immunol. 1984; 4:364-369.
20. Sengar, DPS, Rachid A. and Harris. J E. In vitro cellular immunity and in vitro delayed hypersensitivity in uraemic patients maintained on haemodialysis. Int. Arch. Allergy 1974; 47:829.
21. Sing, S. Hurtubise, P., Michael, G. Pesce, A. and Pollak, V. Preliminary observations on the laboratory markers of cell-mediated immunity in patients transferring from haemodialysis to continuous ambulatory peritoneal dialysis. Contrib. Nephrol. 1983; 36:73-81.
22. Barsott, G., Bevilacqua, G., Morelli, E., Capelli, P., Balesti, P.L. and Giovanetti S Toxicity arising from guanidine compounds: Role of methyl guanidine as uraemic toxin. Kidney Int. 1989; 36:636-44.
23. Nanishi, F., Inenaga, T., Onoyama, K., Oh, Y., Oochi, N. and Fujishima, M. Immune alterations in haemodialysed patients. Effect of blood transfusion on T-lymphocyte subpopulations in haemodialysed patients. J. Clin. Lab. Immunol. 1986; 19:167-174.